MFDS
- Status: likely_approved
🇰🇷 Mobic in South Korea
Mobic (MELOXICAM) regulatory status in South Korea.
Marketing authorisation
Mobic in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Mobic approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Mobic in South Korea?
Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.